Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.,Journal of Internal Medicine

当前位置： X-MOL 学术 › J. Intern. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
Journal of Internal Medicine ( IF 11.1 ) Pub Date : 2019-12-17 , DOI: 10.1111/joim.13017
E Björnson ₁ , C J Packard ₂ , M Adiels ₁ , L Andersson ₁ , N Matikainen _{3,

4} , S Söderlund _{3,

4} , J Kahri ₅ , A Hakkarainen _{6,

7} , N Lundbom ₆ , J Lundbom ₆ , C Sihlbom ₈ , A Thorsell ₈ , H Zhou ₉ , M-R Taskinen ₃ , J Borén _{1,

10}

Affiliation

Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Research Programs Unit, Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland.
Endocrinology, Abdominal Center, Helsinki University Hospital, Helsinki, Finland.
Department of Internal Medicine and Rehabilitation, Helsinki University Hospital, Helsinki, Finland.
Radiology, HUS Medical Imaging Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Department of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland.
Proteomics Facility, University of Gothenburg, Gothenburg, Sweden.
Merck Research Laboratories, Merck & Co. Inc., Kenilworth, NJ, USA.
Sahlgrenska University Hospital, Gothenburg, Sweden.

Renewed interest in triglyceride‐rich lipoproteins as causative agents in cardiovascular disease mandates further exploration of the integrated metabolism of chylomicrons and very low‐density lipoproteins (VLDL).

中文翻译：